Asthma is refered to a chronic respiratory disease which blocks the airways of lung because of mucus production, inflammation, and tightening of muscles. Similarly, Chronic Obstructive Pulmonary Disease(COPD) is caused by the blockade in the airways further resulting in difficulty in breathing, owing to the primary cause as tobacco smoking. Asthma and COPD Devices are the Devices which are used to treat these afore-mentioned respiratory diseases.
This report contains market size and forecasts of Asthma and COPD Devices in global, including the following market information:
Global Asthma and COPD Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Asthma and COPD Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Asthma and COPD Devices companies in 2021 (%)
The global Asthma and COPD Devices market was valued at 30640 million in 2021 and is projected to reach US$ 41430 million by 2028, at a CAGR of 4.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Inhaler Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Asthma and COPD Devices include AstraZeneca, Boehringer Ingelheim, Drive DeVilbiss Healthcare, GF Health Products, Glaxosmithcline, Invacare, Merck, Omron Healthcare and PARI Pharma and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Asthma and COPD Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Asthma and COPD Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Asthma and COPD Devices Market Segment Percentages, by Type, 2021 (%)
Inhaler
Nebulizer
Global Asthma and COPD Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Asthma and COPD Devices Market Segment Percentages, by Application, 2021 (%)
Hospital
Online Store
Medical Machinery Sales Center
Other
Global Asthma and COPD Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Asthma and COPD Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Asthma and COPD Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Asthma and COPD Devices revenues share in global market, 2021 (%)
Key companies Asthma and COPD Devices sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Asthma and COPD Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Boehringer Ingelheim
Drive DeVilbiss Healthcare
GF Health Products
Glaxosmithcline
Invacare
Merck
Omron Healthcare
PARI Pharma
Philips Healthcare